Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Breast Cancer Res Treat. 2020 Apr 13;181(2):309–322. doi: 10.1007/s10549-020-05630-5

Figure 2.

Figure 2

Lymphovascular invasion (LVI) and clinical and pathological features. a LVI incidence rates (fractions) in the TCGA-BRCA and validation cohorts are plotted for different features. P values were determined with Fisher’s exact test. Median value was used to classify tumors into two groups by their MKI67 gene expression. LN, lymph node. b Kaplan-Meier survival plots along with log-rank test p values are shown for overall survival among LVI-positive and -negative cases of the TCGA cohort sub-grouped by TNM T and N status and pathologic stage.